sanguinarine has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holy, J; Lamont, G; Perkins, E | 1 |
| Choi, YJ; Eom, S; Kang, LJ; Kim, C; Lee, J; Lee, JH; Lee, S; Lee, SG; Nguyen, CN; Nguyen, KVA | 1 |
2 other study(ies) available for sanguinarine and cyclin d1
| Article | Year |
|---|---|
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine.
Topics: Active Transport, Cell Nucleus; Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzophenanthridines; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cyclin D1; Cytoplasm; DNA Topoisomerases, Type II; DNA, Neoplasm; Female; Humans; Isoquinolines | 2006 |
Regulation of p21 expression for anti-apoptotic activity of DDX3 against sanguinarine-induced cell death on intrinsic pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzophenanthridines; Caspase 3; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; DEAD-box RNA Helicases; Gene Expression Regulation; HeLa Cells; Humans; Isoquinolines; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2019 |